© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Utah Medical Products, Inc. (UTMD) shows an Average True Range (ATR) of 1.39 and an Enterprise Value of 148.51M. Its average trading volume over the past 3 months is 11.51K, indicating liquidity. These fundamental metrics provide insight into UTMD's underlying financial health and market activity.
Utah Medical Products, Inc. (UTMD) technical indicators as of December 22, 2025: the SMA 20 is 0.47%, SMA 50 at -1.42%, and SMA 200 at -1.1%. The RSI 14 value is 48.43, suggesting its current momentum. These technical analysis signals help assess UTMD's price trends and potential future movements.
Utah Medical Products, Inc. (UTMD) stock performance overview as of December 22, 2025: The 52-week high is $65.56 (currently -13.67% below), and the 52-week low is $51.26 (currently 10.42% above). Over the past year, UTMD's performance is -10.03%, compared to the S&P 500's 12.87% change.
According to market data, Utah Medical Products, Inc. (UTMD) stock's recent performance metrics show that over the last month, UTMD is 3.61%, with a Year-to-Date (YTD) performance of -7.92%. Over the past year, the stock has seen a -10.03% change. These figures summarize UTMD's price movements across various periods, reflecting its historical returns.
According to current financial data, UTMD stock's P/E (TTM) ratio is 16.12, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for UTMD, including P/S (4.69), P/B (1.58), and P/FCF (12.93), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.